{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:14:35Z","timestamp":1791328475416,"version":"4.3.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","award":["Faculty Grants Program"],"award-info":[{"award-number":["Faculty Grants Program"]}],"id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"name":"School of Dentistry, University of California Los Angeles","award":["School of Dentistry"],"award-info":[{"award-number":["School of Dentistry"]}]},{"name":"Polish Ministry of Science and Higher Education","award":["Mobility Award"],"award-info":[{"award-number":["Mobility Award"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00262-016-1822-9","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T11:50:13Z","timestamp":1459425013000},"page":"835-845","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Adoptive transfer of osteoclast-expanded natural killer cells for immunotherapy targeting cancer stem-like cells in humanized mice"],"prefix":"10.1007","volume":"65","author":[{"given":"Anna K.","family":"Kozlowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawaljit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paytsar","family":"Topchyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahid","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"1822_CR1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011590","author":"H-C Tseng","year":"2010","unstructured":"Tseng H-C, Arasteh A, Paranjpe A, Teruel A, Yang W, Behel A, Alva JA, Walter G, Head C, Ishikawa T, Herschman HR, Cacalano N, Pyle AD, Park N-H, Jewett A (2010) Increased lysis of stem cells but not their differentiated cells by Natural Killer cells; de-differentiation or reprogramming activates NK cells. PLoS ONE. doi: 10.1371\/journal.pone.0011590","journal-title":"PLoS ONE"},{"issue":"1","key":"1822_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.7150\/jca.5519","volume":"4","author":"A Jewett","year":"2013","unstructured":"Jewett A, Man Y-G, Tseng H-C (2013) Dual functions of Natural Killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues. J Cancer 4(1):12\u201324. doi: 10.7150\/jca.5519","journal-title":"J Cancer"},{"issue":"8","key":"1822_CR3","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.4049\/jimmunol.1500447","volume":"195","author":"E Ames","year":"2015","unstructured":"Ames E, Canter RJ, Grossenbacher SK, Mac S, Chen M, Smith RC, Hagino T, Perez-Cunningham J, Sckisel GD, Urayama S, Monjazeb AM, Fragoso RC, Sayers TJ, Murphy WJ (2015) NK cells preferentially target tumor cells with a cancer stem cell phenotype. J Immunol 195(8):4010\u20134019. doi: 10.4049\/jimmunol.1500447","journal-title":"J Immunol"},{"issue":"10","key":"1822_CR4","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.4049\/jimmunol.159.10.4815","volume":"159","author":"A Jewett","year":"1997","unstructured":"Jewett A, Cavalcanti M, Bonavida B (1997) Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells. J Immunol 159(10):4815\u20134822","journal-title":"J Immunol"},{"issue":"1","key":"1822_CR5","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0008-8749(95)80013-9","volume":"160","author":"A Jewett","year":"1995","unstructured":"Jewett A, Bonavida B (1995) Target-induced anergy of Natural Killer cytotoxic function is restricted to the NK-target conjugate subset. Cell Immunol 160(1):91\u201397","journal-title":"Cell Immunol"},{"issue":"1","key":"1822_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/clim.2000.4871","volume":"96","author":"A Jewett","year":"2000","unstructured":"Jewett A, Bonavida B (2000) MHC-Class I antigens regulate both the function and the survival of human peripheral blood NK cells: role of endogenously secreted TNF-alpha. Clin Immunol 96(1):19\u201328","journal-title":"Clin Immunol"},{"issue":"7 Pt 1","key":"1822_CR7","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1158\/1078-0432.CCR-05-2306","volume":"12","author":"A Jewett","year":"2006","unstructured":"Jewett A, Cacalano NA, Head C, Teruel A (2006) Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive Natural Killer cells. Clin Cancer Res 12(7 Pt 1):1994\u20132003","journal-title":"Clin Cancer Res"},{"issue":"7","key":"1822_CR8","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00262-007-0437-6","volume":"57","author":"A Jewett","year":"2008","unstructured":"Jewett A, Teruel A, Romero M, Head C, Cacalano N (2008) Rapid and potent induction of cell death and loss of NK cell cytotoxicity against oral tumors by F(ab\u2019)2 fragment of anti-CD16 antibody. Cancer Immunol Immunother: CII 57(7):1053\u20131066","journal-title":"Cancer Immunol Immunother: CII"},{"issue":"3","key":"1822_CR9","doi-asserted-by":"crossref","first-page":"907","DOI":"10.4049\/jimmunol.156.3.907","volume":"156","author":"A Jewett","year":"1996","unstructured":"Jewett A, Bonavida B (1996) Target-induced inactivation and cell death by apoptosis in a subset of human NK cells. J Immunol 156(3):907\u2013915","journal-title":"J Immunol"},{"key":"1822_CR10","doi-asserted-by":"publisher","first-page":"269","DOI":"10.3389\/fimmu.2014.00269","volume":"5","author":"H-C Tseng","year":"2014","unstructured":"Tseng H-C, Bui V, Man Y-G, Cacalano N, Jewett A (2014) Induction of split anergy conditions Natural Killer cells to promote differentiation of stem cells through cell\u2013cell contact and secreted factors. Front Immunol 5:269. doi: 10.3389\/fimmu.2014.00269","journal-title":"Front Immunol"},{"issue":"11","key":"1822_CR11","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.18632\/oncotarget.3250","volume":"6","author":"HC Tseng","year":"2015","unstructured":"Tseng HC, Cacalano N, Jewett A (2015) Split anergized Natural Killer cells halt inflammation by inducing stem cell differentiation, resistance to NK cell cytotoxicity and prevention of cytokine and chemokine secretion. Oncotarget 6(11):8947\u20138959","journal-title":"Oncotarget"},{"issue":"5","key":"1822_CR12","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","volume":"172","author":"J Mestas","year":"2004","unstructured":"Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172(5):2731\u20132738","journal-title":"J Immunol"},{"key":"1822_CR13","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1146\/annurev-immunol-032712-095921","volume":"31","author":"A Rongvaux","year":"2013","unstructured":"Rongvaux A, Takizawa H, Strowig T, Willinger T, Eynon EE, Flavell RA, Manz MG (2013) Human hemato-lymphoid system mice: current use and future potential for medicine. Annu Rev Immunol 31:635\u2013674. doi: 10.1146\/annurev-immunol-032712-095921","journal-title":"Annu Rev Immunol"},{"issue":"11","key":"1822_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human Natural Killer-cell subsets. Trends Immunol 22(11):633\u2013640","journal-title":"Trends Immunol"},{"key":"1822_CR15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev.immunol.22.012703.104711","volume":"22","author":"WM Yokoyama","year":"2004","unstructured":"Yokoyama WM, Kim S, French AR (2004) The dynamic life of Natural Killer cells. Annu Rev Immunol 22:405\u2013429. doi: 10.1146\/annurev.immunol.22.012703.104711","journal-title":"Annu Rev Immunol"},{"issue":"10","key":"1822_CR16","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.4049\/jimmunol.1101561","volume":"187","author":"K Yoshizawa","year":"2011","unstructured":"Yoshizawa K, Nakajima S, Notake T, Miyagawa S, Hida S, Taki S (2011) IL-15-high-responder developing NK cells bearing Ly49 receptors in IL-15\u00a0\u2212\/\u2212\u00a0mice. J Immunol 187(10):5162\u20135169. doi: 10.4049\/jimmunol.1101561","journal-title":"J Immunol"},{"key":"1822_CR17","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3389\/fimmu.2015.00259","volume":"6","author":"HC Tseng","year":"2015","unstructured":"Tseng HC, Arasteh A, Kaur K, Kozlowska A, Topchyan P, Jewett A (2015) Differential cytotoxicity but augmented IFN-gamma secretion by NK cells after interaction with monocytes from humans, and those from wild type and myeloid-specific COX-2 knockout mice. Front Immunol 6:259. doi: 10.3389\/fimmu.2015.00259","journal-title":"Front Immunol"},{"issue":"5900","key":"1822_CR18","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/301527a0","volume":"301","author":"GC Bosma","year":"1983","unstructured":"Bosma GC, Custer RP, Bosma MJ (1983) A severe combined immunodeficiency mutation in the mouse. Nature 301(5900):527\u2013530","journal-title":"Nature"},{"key":"1822_CR19","unstructured":"Isaacson JH, Cattanach BM (1962) [Report]. Mouse News Lett 27:31"},{"issue":"6","key":"1822_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/00327487708065514","volume":"7","author":"EM Levy","year":"1977","unstructured":"Levy EM, Yonkosky D, Schmid K, Cooperband SR (1977) Enrichment of the murine Natural Killer (NK) and mitogen induced cellular cytotoxicity (MICC) cells using preparative free-flow high voltage electrophoresis. Prep Biochem 7(6):467\u2013478. doi: 10.1080\/00327487708065514","journal-title":"Prep Biochem"},{"key":"1822_CR21","first-page":"v","volume":"324","author":"T Nomura","year":"2008","unstructured":"Nomura T, Watanabe T, Habu S (2008) Humanized mice. Preface. Curr Top Microbiol Immunol 324:v\u2013vi","journal-title":"Curr Top Microbiol Immunol"},{"key":"1822_CR22","first-page":"259","volume":"152","author":"RA Phillips","year":"1989","unstructured":"Phillips RA, Jewett MA, Gallie BL (1989) Growth of human tumors in immune-deficient scid mice and nude mice. Curr Top Microbiol Immunol 152:259\u2013263","journal-title":"Curr Top Microbiol Immunol"},{"issue":"3","key":"1822_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2337\/diab.32.3.247","volume":"32","author":"S Kataoka","year":"1983","unstructured":"Kataoka S, Satoh J, Fujiya H, Toyota T, Suzuki R, Itoh K, Kumagai K (1983) Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 32(3):247\u2013253","journal-title":"Diabetes"},{"issue":"1","key":"1822_CR24","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4049\/jimmunol.154.1.180","volume":"154","author":"LD Shultz","year":"1995","unstructured":"Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL et al (1995) Multiple defects in innate and adaptive immunologic function in NOD\/LtSz-scid mice. J Immunol 154(1):180\u2013191","journal-title":"J Immunol"},{"issue":"11","key":"1822_CR25","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.2337\/diab.42.11.1574","volume":"42","author":"AG Baxter","year":"1993","unstructured":"Baxter AG, Cooke A (1993) Complement lytic activity has no role in the pathogenesis of autoimmune diabetes in NOD mice. Diabetes 42(11):1574\u20131578","journal-title":"Diabetes"},{"issue":"3","key":"1822_CR26","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1002\/stem.160166","volume":"16","author":"DL Greiner","year":"1998","unstructured":"Greiner DL, Hesselton RA, Shultz LD (1998) SCID mouse models of human stem cell engraftment. Stem Cells 16(3):166\u2013177. doi: 10.1002\/stem.160166","journal-title":"Stem Cells"},{"issue":"10","key":"1822_CR27","doi-asserted-by":"publisher","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","volume":"174","author":"LD Shultz","year":"2005","unstructured":"Shultz LD, Lyons BL, Burzenski LM, Gott B, Chen X, Chaleff S, Kotb M, Gillies SD, King M, Mangada J, Greiner DL, Handgretinger R (2005) Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174(10):6477\u20136489","journal-title":"J Immunol"},{"issue":"11","key":"1822_CR28","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1038\/nri3311","volume":"12","author":"LD Shultz","year":"2012","unstructured":"Shultz LD, Brehm MA, Garcia-Martinez JV, Greiner DL (2012) Humanized mice for immune system investigation: progress, promise and challenges. Nat Rev Immunol 12(11):786\u2013798. doi: 10.1038\/nri3311","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"1822_CR29","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1182\/blood-2005-02-0516","volume":"106","author":"F Ishikawa","year":"2005","unstructured":"Ishikawa F, Yasukawa M, Lyons B, Yoshida S, Miyamoto T, Yoshimoto G, Watanabe T, Akashi K, Shultz LD, Harada M (2005) Development of functional human blood and immune systems in NOD\/SCID\/IL2 receptor gamma chain(null) mice. Blood 106(5):1565\u20131573. doi: 10.1182\/blood-2005-02-0516","journal-title":"Blood"},{"issue":"2","key":"1822_CR30","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nri2017","volume":"7","author":"LD Shultz","year":"2007","unstructured":"Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7(2):118\u2013130. doi: 10.1038\/nri2017","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"1822_CR31","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s00262-008-0632-0","volume":"58","author":"A Ito","year":"2009","unstructured":"Ito A, Ishida T, Yano H, Inagaki A, Suzuki S, Sato F, Takino H, Mori F, Ri M, Kusumoto S, Komatsu H, Iida S, Inagaki H, Ueda R (2009) Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD\/Shi-scid, IL-2Rgamma(null) mouse model. Cancer Immunol Immunother 58(8):1195\u20131206. doi: 10.1007\/s00262-008-0632-0","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1822_CR32","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/j.1365-2249.2009.03933.x","volume":"157","author":"MA King","year":"2009","unstructured":"King MA, Covassin L, Brehm MA, Racki W, Pearson T, Leif J, Laning J, Fodor W, Foreman O, Burzenski L, Chase TH, Gott B, Rossini AA, Bortell R, Shultz LD, Greiner DL (2009) Human peripheral blood leucocyte non-obese diabetic-severe combined immunodeficiency interleukin-2 receptor gamma chain gene mouse model of xenogeneic graft-versus-host-like disease and the role of host major histocompatibility complex. Clin Exp Immunol 157(1):104\u2013118. doi: 10.1111\/j.1365-2249.2009.03933.x","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"1822_CR33","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1182\/blood-2009-04-215855","volume":"115","author":"S Shimizu","year":"2010","unstructured":"Shimizu S, Hong P, Arumugam B, Pokomo L, Boyer J, Koizumi N, Kittipongdaja P, Chen A, Bristol G, Galic Z, Zack JA, Yang O, Chen IS, Lee B, An DS (2010) A highly efficient short hairpin RNA potently down-regulates CCR5 expression in systemic lymphoid organs in the hu-BLT mouse model. Blood 115(8):1534\u20131544. doi: 10.1182\/blood-2009-04-215855","journal-title":"Blood"},{"key":"1822_CR34","doi-asserted-by":"publisher","first-page":"e4181","DOI":"10.3791\/4181","volume":"70","author":"DN Vatakis","year":"2012","unstructured":"Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA (2012) Using the BLT humanized mouse as a stem cell based gene therapy tumor model. J Vis Exp 70:e4181. doi: 10.3791\/4181","journal-title":"J Vis Exp"},{"issue":"1","key":"1822_CR35","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.virol.2011.05.013","volume":"417","author":"CA Stoddart","year":"2011","unstructured":"Stoddart CA, Maidji E, Galkina SA, Kosikova G, Rivera JM, Moreno ME, Sloan B, Joshi P, Long BR (2011) Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rgamma(\u2212\/\u2212) (NSG) BLT mice. Virology 417(1):154\u2013160. doi: 10.1016\/j.virol.2011.05.013","journal-title":"Virology"},{"issue":"5667","key":"1822_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.1093933","volume":"304","author":"E Traggiai","year":"2004","unstructured":"Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304(5667):104\u2013107. doi: 10.1126\/science.1093933","journal-title":"Science"},{"issue":"9","key":"1822_CR37","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1182\/blood-2001-12-0207","volume":"100","author":"M Ito","year":"2002","unstructured":"Ito M, Hiramatsu H, Kobayashi K, Suzue K, Kawahata M, Hioki K, Ueyama Y, Koyanagi Y, Sugamura K, Tsuji K, Heike T, Nakahata T (2002) NOD\/SCID\/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. Blood 100(9):3175\u20133182. doi: 10.1182\/blood-2001-12-0207","journal-title":"Blood"},{"issue":"20","key":"1822_CR38","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1182\/blood-2010-02-270678","volume":"116","author":"T Strowig","year":"2010","unstructured":"Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, R\u00e4mer PC, Ferlazzo G, M\u00fcnz C (2010) Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116(20):4158\u20134167. doi: 10.1182\/blood-2010-02-270678","journal-title":"Blood"},{"issue":"2","key":"1822_CR39","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jri.2010.11.005","volume":"88","author":"R Olesen","year":"2011","unstructured":"Olesen R, Wahl A, Denton PW, Garcia JV (2011) Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection. J Reprod Immunol 88(2):195\u2013203. doi: 10.1016\/j.jri.2010.11.005","journal-title":"J Reprod Immunol"},{"issue":"1","key":"1822_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1128\/JVI.06120-11","volume":"86","author":"PW Denton","year":"2012","unstructured":"Denton PW, Olesen R, Choudhary SK, Archin NM, Wahl A, Swanson MD, Chateau M, Nochi T, Krisko JF, Spagnuolo RA, Margolis DM, Garcia JV (2012) Generation of HIV latency in humanized BLT mice. J Virol 86(1):630\u2013634. doi: 10.1128\/JVI.06120-11","journal-title":"J Virol"},{"issue":"5","key":"1822_CR41","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.immuni.2007.05.001","volume":"26","author":"MG Manz","year":"2007","unstructured":"Manz MG (2007) Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 26(5):537\u2013541. doi: 10.1016\/j.immuni.2007.05.001","journal-title":"Immunity"},{"issue":"51","key":"1822_CR42","doi-asserted-by":"publisher","first-page":"E1408","DOI":"10.1073\/pnas.1115050108","volume":"108","author":"DN Vatakis","year":"2011","unstructured":"Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A, Radu CG, Galic Z, Zack JA (2011) Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells. Proc Natl Acad Sci USA 108(51):E1408\u2013E1416. doi: 10.1073\/pnas.1115050108","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"1822_CR43","doi-asserted-by":"publisher","first-page":"e8379","DOI":"10.1371\/journal.pone.0008379","volume":"4","author":"A Kwant-Mitchell","year":"2009","unstructured":"Kwant-Mitchell A, Pek EA, Rosenthal KL, Ashkar AA (2009) Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge. PLoS ONE 4(12):e8379. doi: 10.1371\/journal.pone.0008379","journal-title":"PLoS ONE"},{"issue":"1\u20132","key":"1822_CR44","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.imbio.2010.04.008","volume":"216","author":"EA Pek","year":"2011","unstructured":"Pek EA, Chan T, Reid S, Ashkar AA (2011) Characterization and IL-15 dependence of NK cells in humanized mice. Immunobiology 216(1\u20132):218\u2013224. doi: 10.1016\/j.imbio.2010.04.008","journal-title":"Immunobiology"},{"issue":"51","key":"1822_CR45","doi-asserted-by":"publisher","first-page":"21783","DOI":"10.1073\/pnas.0912274106","volume":"106","author":"Q Chen","year":"2009","unstructured":"Chen Q, Khoury M, Chen J (2009) Expression of human cytokines dramatically improves reconstitution of specific human-blood lineage cells in humanized mice. Proc Natl Acad Sci USA 106(51):21783\u201321788. doi: 10.1073\/pnas.0912274106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1822_CR46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1084\/jem.20082013","volume":"206","author":"ND Huntington","year":"2009","unstructured":"Huntington ND, Legrand N, Alves NL, Jaron B, Weijer K, Plet A, Corcuff E, Mortier E, Jacques Y, Spits H, Di Santo JP (2009) IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med 206(1):25\u201334. doi: 10.1084\/jem.20082013","journal-title":"J Exp Med"},{"issue":"5","key":"1822_CR47","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.4049\/jimmunol.1000583","volume":"185","author":"MC Andre","year":"2010","unstructured":"Andre MC, Erbacher A, Gille C, Schmauke V, Goecke B, Hohberger A, Mang P, Wilhelm A, Mueller I, Herr W, Lang P, Handgretinger R, Hartwig UF (2010) Long-term human CD34+ stem cell-engrafted nonobese diabetic\/SCID\/IL-2R gamma(null) mice show impaired CD8+ T cell maintenance and a functional arrest of immature NK cells. J Immunol 185(5):2710\u20132720. doi: 10.4049\/jimmunol.1000583","journal-title":"J Immunol"},{"issue":"7","key":"1822_CR48","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.V87.7.2632.bloodjournal8772632","volume":"87","author":"E Mrozek","year":"1996","unstructured":"Mrozek E, Anderson P, Caligiuri MA (1996) Role of interleukin-15 in the development of human CD56+ Natural Killer cells from CD34+ hematopoietic progenitor cells. Blood 87(7):2632\u20132640","journal-title":"Blood"},{"issue":"4","key":"1822_CR49","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0301-472X(99)00005-3","volume":"27","author":"T Sato","year":"1999","unstructured":"Sato T, Laver JH, Aiba Y, Ogawa M (1999) NK cell colony formation from human fetal thymocytes. Exp Hematol 27(4):726\u2013733","journal-title":"Exp Hematol"},{"issue":"3","key":"1822_CR50","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.4049\/jimmunol.174.3.1213","volume":"174","author":"CA Vosshenrich","year":"2005","unstructured":"Vosshenrich CA, Ranson T, Samson SI, Corcuff E, Colucci F, Rosmaraki EE, Di Santo JP (2005) Roles for common cytokine receptor gamma-chain-dependent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 174(3):1213\u20131221","journal-title":"J Immunol"},{"key":"1822_CR51","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.0105-2896.2005.00223.x","volume":"203","author":"A Fischer","year":"2005","unstructured":"Fischer A, Le Deist F, Hacein-Bey-Abina S, Andre-Schmutz I, Basile Gde S, de Villartay JP, Cavazzana-Calvo M (2005) Severe combined immunodeficiency. A model disease for molecular immunology and therapy. Immunol Rev 203:98\u2013109. doi: 10.1111\/j.0105-2896.2005.00223.x","journal-title":"Immunol Rev"},{"issue":"47","key":"1822_CR52","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1073\/pnas.0407522101","volume":"101","author":"G Ferlazzo","year":"2004","unstructured":"Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, Strowig T, Bougras G, Muller WA, Moretta L, Munz C (2004) Distinct roles of IL-12 and IL-15 in human Natural Killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 101(47):16606\u201316611. doi: 10.1073\/pnas.0407522101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"1822_CR53","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1182\/blood-2010-02-270678","volume":"116","author":"T Strowig","year":"2010","unstructured":"Strowig T, Chijioke O, Carrega P, Arrey F, Meixlsperger S, Ramer PC, Ferlazzo G, Munz C (2010) Human NK cells of mice with reconstituted human immune system components require preactivation to acquire functional competence. Blood 116(20):4158\u20134167. doi: 10.1182\/blood-2010-02-270678","journal-title":"Blood"},{"issue":"9","key":"1822_CR54","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/ijc.26159","volume":"129","author":"AK Wege","year":"2011","unstructured":"Wege AK, Ernst W, Eckl J, Frankenberger B, Vollmann-Zwerenz A, M\u00e4nnel DN, Ortmann O, Kroemer A, Brockhoff G (2011) Humanized tumor mice\u2014a new model to study and manipulate the immune response in advanced cancer therapy. Int J Cancer 129(9):2194\u20132206. doi: 10.1002\/ijc.26159","journal-title":"Int J Cancer"},{"issue":"1","key":"1822_CR55","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00262-013-1501-z","volume":"63","author":"MR Shurin","year":"2014","unstructured":"Shurin MR, Umansky V, Malyguine A, Hurwitz AA, Apte RN, Whiteside T, Jewett A, Thanavala Y, Murphy WJ (2014) Cellular and molecular pathways in the tumor immunoenvironment: 3rd Cancer Immunotherapy and Immunomonitoring (CITIM) meeting, 22\u201325 April 2013, Krakow, Poland. Cancer Immunol Immunother 63(1):73\u201380. doi: 10.1007\/s00262-013-1501-z","journal-title":"Cancer Immunol Immunother"},{"issue":"8","key":"1822_CR56","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nri2604","volume":"9","author":"DH Raulet","year":"2009","unstructured":"Raulet DH, Guerra N (2009) Oncogenic stress sensed by the immune system: role of Natural Killer cell receptors. Nat Rev Immunol 9(8):568\u2013580. doi: 10.1038\/nri2604","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"1822_CR57","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-11-2544","volume":"72","author":"G Pietra","year":"2012","unstructured":"Pietra G, Manzini C, Rivara S, Vitale M, Cantoni C, Petretto A, Balsamo M, Conte R, Benelli R, Minghelli S, Solari N, Gualco M, Queirolo P, Moretta L, Mingari MC (2012) Melanoma cells inhibit Natural Killer cell function by modulating the expression of activating receptors and cytolytic activity. Cancer Res 72(6):1407\u20131415. doi: 10.1158\/0008-5472.CAN-11-2544","journal-title":"Cancer Res"},{"key":"1822_CR58","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/1471-2407-9-186","volume":"9","author":"T Garcia-Iglesias","year":"2009","unstructured":"Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Duenas MG, Balderas-Pena LM, Bravo-Cuellar A, Ortiz-Lazareno PC, Daneri-Navarro A (2009) Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC Cancer 9:186. doi: 10.1186\/1471-2407-9-186","journal-title":"BMC Cancer"},{"key":"1822_CR59","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1186\/1471-2407-14-738","volume":"14","author":"YP Peng","year":"2014","unstructured":"Peng YP, Zhang JJ, Liang WB, Tu M, Lu ZP, Wei JS, Jiang KR, Gao WT, Wu JL, Xu ZK, Miao Y, Zhu Y (2014) Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates Natural Killer cell dysfunction. BMC Cancer 14:738. doi: 10.1186\/1471-2407-14-738","journal-title":"BMC Cancer"},{"issue":"21","key":"1822_CR60","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-11-0792","volume":"71","author":"E Mamessier","year":"2011","unstructured":"Mamessier E, Sylvain A, Bertucci F, Castellano R, Finetti P, Houvenaeghel G, Charaffe-Jaufret E, Birnbaum D, Moretta A, Olive D (2011) Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition. Cancer Res 71(21):6621\u20136632. doi: 10.1158\/0008-5472.CAN-11-0792","journal-title":"Cancer Res"},{"issue":"6","key":"1822_CR61","first-page":"1369","volume":"5","author":"Z Chen","year":"1999","unstructured":"Chen Z, Malhotra PS, Thomas GR, Ondrey FG, Duffey DC, Smith CW, Enamorado I, Yeh NT, Kroog GS, Rudy S, McCullagh L, Mousa S, Quezado M, Herscher LL, Van Waes C (1999) Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer. Clin Cancer Res 5(6):1369\u20131379","journal-title":"Clin Cancer Res"},{"issue":"24","key":"1822_CR62","doi-asserted-by":"publisher","first-page":"20002","DOI":"10.18632\/oncotarget.4755","volume":"6","author":"HC Tseng","year":"2015","unstructured":"Tseng HC, Kanayama K, Kaur K, Park SH, Park S, Kozlowska A, Sun S, McKenna CE, Nishimura I, Jewett A (2015) Bisphosphonate-induced differential modulation of immune cell function in gingiva and bone marrow in vivo: role in osteoclast-mediated NK cell activation. Oncotarget 6(24):20002\u201320025","journal-title":"Oncotarget"},{"issue":"6","key":"1822_CR63","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1073\/pnas.0813192106","volume":"106","author":"MA Cooper","year":"2009","unstructured":"Cooper MA, Elliott JM, Keyel PA, Yang L, Carrero JA, Yokoyama WM (2009) Cytokine-induced memory-like Natural Killer cells. Proc Natl Acad Sci USA 106(6):1915\u20131919. doi: 10.1073\/pnas.0813192106","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1822_CR64","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ejca.2003.11.028","volume":"40","author":"LR Kelland","year":"2004","unstructured":"Kelland LR (2004) Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development. Eur J Cancer 40(6):827\u2013836. doi: 10.1016\/j.ejca.2003.11.028","journal-title":"Eur J Cancer"},{"issue":"9","key":"1822_CR65","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.4049\/jimmunol.150.9.3817","volume":"150","author":"S Nonoyama","year":"1993","unstructured":"Nonoyama S, Smith FO, Bernstein ID, Ochs HD (1993) Strain-dependent leakiness of mice with severe combined immune deficiency. J Immunol 150(9):3817\u20133824","journal-title":"J Immunol"},{"key":"1822_CR66","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1101\/pdb.top073585","volume":"7","author":"LD Shultz","year":"2014","unstructured":"Shultz LD, Goodwin N, Ishikawa F, Hosur V, Lyons BL, Greiner DL (2014) Human cancer growth and therapy in immunodeficient mouse models. Cold Spring Harb Protoc 7:694\u2013708. doi: 10.1101\/pdb.top073585","journal-title":"Cold Spring Harb Protoc"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-016-1822-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1822-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-016-1822-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T12:12:09Z","timestamp":1692274329000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-016-1822-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":66,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["1822"],"URL":"https:\/\/doi.org\/10.1007\/s00262-016-1822-9","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]},"assertion":[{"value":"30 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}